Latest / Oncology Data Advisor
Expanding Clinical Trial Access With Decentralization and Technology: Waqas Haque and Shaalan Beg
In this installment of Oncology Data Advisor's Exploring AI in Oncology series, Dr. Waqas Haque speaks with Dr. Shaalan Beg, an Adjunct Associate Professor at the University of Texas (UT) Southwestern, who is spearheading efforts to decentralize clinical trials in oncology and expand access for eligible patients. Dr. Beg describes the tools that are currently in development for decentralizing trials, including the use of artificial intelligence (AI), natural language processing, and telehealth. Additionally, he shares his perspectives on transitioning to a career in industry.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.